The reduction in both hepatic steatosis and hepatic gluconeogenesis would follow from improved iWAT insulin sensitivity and hepatic insulin sensitivity, respectively, which we demonstrated by the assessment of insulin-stimulated AKT phosphorylation in those tissues. Here, AKT1 is linked to fatty liver disease.